Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 22, 2017Molecular Cancer Therapeutics

Role of STAT3 and FOXO1 in the Divergent Therapeutic Responses of Non-metastatic and Metastatic Bladder Cancer Cells to miR-145

View Full Paper
Ask AI
Bookmark
Share

Authors

GJGuosong JiangUnion HospitalCHChao HuangGuangdong Pharmaceutical UniversityCHChao HuangGuangdong Pharmaceutical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jiang et al. (2017) studied this question.

synapsesocial.com/papers/6a83fbae062e2d56a83e9738https://doi.org/10.1158/1535-7163.mct-16-0631
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells2009 · 565 citations
  2. 2IKKβ programs to turn on the GADD45α–MKK4–JNK apoptotic cascade specifically via p50 NF-κB in arsenite response2006 · 93 citations
  3. 3Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival2008 · 139 citations
  4. 4JNK1 Mediates Degradation HIF-1α by a VHL-Independent Mechanism that Involves the Chaperones Hsp90/Hsp702010 · 101 citations
  5. 5The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer2011 · 123 citations